| Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis M Drolet, É Bénard, N Pérez, M Brisson, H Ali, MC Boily, V Baldo, ... The Lancet 394 (10197), 497-509, 2019 | 955 | 2019 |
| Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis M Drolet, É Bénard, MC Boily, H Ali, L Baandrup, H Bauer, S Beddows, ... The Lancet infectious diseases 15 (5), 565-580, 2015 | 881 | 2015 |
| Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries M Brisson, JJ Kim, K Canfell, M Drolet, G Gingras, EA Burger, D Martin, ... The Lancet 395 (10224), 575-590, 2020 | 699 | 2020 |
| Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis T Malagón, M Drolet, MC Boily, EL Franco, M Jit, J Brisson, M Brisson The Lancet infectious diseases 12 (10), 781-789, 2012 | 562 | 2012 |
| Epidemiology of varicella zoster virus infection in Canada and the United Kingdom M Brisson, WJ Edmunds, B Law, NJ Gay, R Walld, M Brownell, LL Roos, ... Epidemiology & Infection 127 (2), 305-314, 2001 | 506 | 2001 |
| Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries K Canfell, JJ Kim, M Brisson, A Keane, KT Simms, M Caruana, EA Burger, ... The Lancet 395 (10224), 591-603, 2020 | 496 | 2020 |
| Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox M Brisson, NJ Gay, WJ Edmunds, NJ Andrews Vaccine 20 (19-20), 2500-2507, 2002 | 428 | 2002 |
| The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study M Drolet, M Brisson, KE Schmader, MJ Levin, R Johnson, MN Oxman, ... Cmaj 182 (16), 1731-1736, 2010 | 361 | 2010 |
| Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic … M Brisson, É Bénard, M Drolet, JA Bogaards, I Baussano, S Vänskä, M Jit, ... The Lancet Public Health 1 (1), e8-e17, 2016 | 322 | 2016 |
| Modelling the impact of immunization on the epidemiology of varicella zoster virus M Brisson, WJ Edmunds, NJ Gay, B Law, G De Serres Epidemiology & Infection 125 (3), 651-669, 2000 | 319 | 2000 |
| Economic evaluation of vaccination programs: the impact of herd-immunity M Brisson, WJ Edmunds Medical Decision Making 23 (1), 76-82, 2003 | 312 | 2003 |
| Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study M Jit, M Brisson, A Portnoy, R Hutubessy The Lancet Global health 2 (7), e406-e414, 2014 | 302 | 2014 |
| Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study X Li, C Mukandavire, ZM Cucunubá, SE Londono, K Abbas, HE Clapham, ... The Lancet 397 (10272), 398-408, 2021 | 236 | 2021 |
| Dynamic transmission modeling: a report of the ISPOR-SMDM modeling good research practices task force-5 R Pitman, D Fisman, GS Zaric, M Postma, M Kretzschmar, J Edmunds, ... Value in health 15 (6), 828-834, 2012 | 236 | 2012 |
| The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales WJ Edmunds, M Brisson, JD Rose Vaccine 19 (23-24), 3076-3090, 2001 | 234 | 2001 |
| The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada M Brisson, N Van de Velde, P De Wals, MC Boily Vaccine 25 (29), 5399-5408, 2007 | 221 | 2007 |
| Epidemiology of varicella‐zoster virus in England and Wales M Brisson, WJ Edmunds Journal of medical virology 70 (S1), S9-S14, 2003 | 186 | 2003 |
| Accounting for methodological, structural, and parameter uncertainty in decision-analytic models: a practical guide J Bilcke, P Beutels, M Brisson, M Jit Medical Decision Making 31 (4), 675-692, 2011 | 182 | 2011 |
| Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults JM Pellissier, M Brisson, MJ Levin Vaccine 25 (49), 8326-8337, 2007 | 181 | 2007 |
| Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model–based analysis N Van de Velde, MC Boily, M Drolet, EL Franco, MH Mayrand, EV Kliewer, ... Journal of the National Cancer Institute 104 (22), 1712-1723, 2012 | 175 | 2012 |
